Veracyte, Inc.

US$24.16As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VCYTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 12.75%
Div yield —
ROE 9.43%
Diagnostics & Research
Beta (5Y) 1.96
PE TTM 15.78
TSR TTM (33.04%)
Mkt cap US$1.950B
ROIC 8.54%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$25
2.68%
(48.06%)
Buy 4|6|8|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.62
0.69
0.75
0.83
16.55%
21.01%
31.36%
48.64%
Revenue$M
146.8
148.4
145.6
148.3
13.27%
8.11%
8.95%
4.71%
Peers (US$1.950B)
Cap (US$)
PE
2.179B
—
1.712B
—
1.960B
47.34x
Capital
TTM
5Y
10Y
Leveragex
2.915
0.247
0.206
EBIT/Intx
0.358
1.767
1.359
Own earn%
(346.09)
(113.59)
(115.83)
Sh yield%
43.34
32.28
32.60
Owners
Insiders/Inst%
8.67
32.39
Short interest%
3.60
SBC / revenue%
1.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
11–17
$1 testx
0.0
Incr. ROIC%
10